Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production

Journal of Neuroimmunology

Volumn 151, Issue 1-2, 2004, Pages 180-188

  DeRijk, Roel H ^a,b   Eskandari, Farideh ^a   Sternberg, Esther M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Psychiatric Hospital Endegeest   (Netherlands)

Author keywords

Corticosteroid sensitivity; Cortisol; Dexamethasone; IL 6 production; Multiple sclerosis

Indexed keywords

15 DEOXYSPERGUALINE; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; INTERFERON BETA SERINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HORMONE INHIBITION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; BLOOD CELLS; CELLS, CULTURED; DEXAMETHASONE; DRUG RESISTANCE; FEMALE; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROGNOSIS;

EID: 2442604431     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.02.009     Document Type: Article

References (60)

1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). Faseb J. 4:1990;2860-2867
2. Bamberger C.M., Bamberger A.M., de Castro M., Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95:1995;2435-2441
3. Bamberger C.M., Schulte H.M., Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17:1996;245-261
4. Bendtzen K. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol. Lett. 19:1988;183-191
5. Buske-Kirschbaum A., Geiben A., Hollig H., Morschhauser E., Hellhammer D. Altered responsiveness of the hypothalamic-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J. Clin. Endocrinol. Metab. 87:2002;4245-4251
6. Chikanza I.C., Petrou P., Kingsley G., Chrousos G., Panayi G.S. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1992;1281-1288
7. Cupps T.R., Fauci A.S. Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 65:1982;133-155
8. Demitrack M.A., Crofford L.J. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 840:1998;684-697
9. Derijk R., Sternberg E.M. Corticosteroid action and neuroendocrine-immune interactions. Ann. N. Y. Acad. Sci. 746:1994;33-41. (discussion 64-37)
10. DeRijk R.H., Petrides J., Deuster P., Gold P.W., Sternberg E.M. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J. Clin. Endocrinol. Metab. 81:1996;228-235
11. DeRijk R., Michelson D., Karp B., Petrides J., Galliven E., Deuster P., Paciotti G., Gold P.W., Sternberg E.M. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J. Clin. Endocrinol. Metab. 82:1997;2182-2191
12. DeRijk R.H., Sternberg E.M., de Kloet E.R. Glucocorticoid receptor function in health and disease. Curr. Opin. Endocrinol. Diabetes. 4:1997;185-193
13. Derijk R.H., Schaaf M.J., Turner G., Datson N.A., Vreugdenhil E., Cidlowski J., de Kloet E.R., Emery P., Sternberg E.M., Detera-Wadleigh S.D. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28:2001;2383-2388
14. DeRijk R.H., Schaaf M., de Kloet E.R. Glucocorticoid receptor variants: clinical implications. J. Steroid Biochem. Mol. Biol. 81:2002;103-122
15. Dhabhar F.S. Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann. N. Y. Acad. Sci. 992:2003;205-217
16. Dietrich H.M., Oliveira-dos-Santos A.J., Wick G. Development of spontaneous autoimmune thyroiditis in obese strain (OS) chickens. Vet. Immunol. Immunopathol. 57:1997;141-146
17. Duclos M., Gouarne C., Bonnemaison D. Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids. J. Appl. Physiol. 94:2003;869-875
18. Ebrecht M., Buske-Kirschbaum A., Hellhammer D., Kern S., Rohleder N., Walker B., Kirschbaum C. Tissue specificity of glucocorticoid sensitivity in healthy adults. J. Clin. Endocrinol. Metab. 85:2000;3733-3739
19. Erkut Z.A., Hofman M.A., Ravid R., Swaab D.F. Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J. Neuroimmunol. 62:1995;27-33
20. Eskandari F., Sternberg E.M. Neural-immune interactions in health and disease. Ann. N. Y. Acad. Sci. 966:2002;20-27
21. Eugster H.P., Frei K., Kopf M., Lassmann H., Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;2178-2187
22. Grasser A., Moller A., Backmund H., Yassouridis A., Holsboer F. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp. Clin. Endocrinol. Diabetes. 104:1996;31-37
23. Gutierrez M.A., Garcia M.E., Rodriguez J.A., Rivero S., Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus. 7:1998;404-408
24. Gutierrez M.A., Garcia M.E., Rodriguez J.A., Mardonez G., Jacobelli S., Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J. Rheumatol. 26:1999;277-281
25. Heesen C., Schulz H., Schmidt M., Gold S., Tessmer W., Schulz K.H. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav. Immun. 16:2002;282-287
26. Henneberg A., Mayle D.M., Kornhuber H.H. Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis. J. Neuroimmunol. 34:1991;223-227
27. Henneberg A.E., Elsner U., Kornhuber H.H. Absence of brain antibodies in the sera of relapsing-remitting multiple sclerosis patients is not due to the formation of immune complexes. Acta Neurol. Scand. 87:1993;455-456
28. Hill M.R., Stith R.D., McCallum R.E. Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells. J. Immunol. 141:1988;1522-1528
29. Johnson E.O., Vlachoyiannopoulos P.G., Skopouli F.N., Tzioufas A.G., Moutsopoulos H.M. Hypofunction of the stress axis in Sjogren's syndrome. J. Rheumatol. 25:1998;1508-1514
30. Kam J.C., Szefler S.J., Surs W., Sher E.R., Leung D.Y. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151:1993;3460-3466
31. Kleine T.O., Zwerenz P., Graser C., Zofel P. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8. Brain Res. Bull. 61:2003;327-346
32. Lamberts S.W., Huizenga A.T., de Lange P., de Jong F.H., Koper J.W. Clinical aspects of glucocorticoid sensitivity. Steroids. 61:1996;157-160
33. Lechner O., Hu Y., Jafarian-Tehrani M., Dietrich H., Schwarz S., Herold M., Haour F., Wick G. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav. Immun. 10:1996;337-350
34. Mason D., MacPhee I., Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology. 70:1990;1-5
35. Mendel I., Katz A., Kozak N., Ben-Nun A., Revel M. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1998;1727-1737
36. Michelson D., Stone L., Galliven E., Magiakou M.A., Chrousos G.P., Sternberg E.M., Gold P.W. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J. Clin. Endocrinol. Metab. 79:1994;848-853
37. Neek G., Kluter A., Dotzlaw H.M.E. Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis. Ann. N. Y. Acad. Sci. 966:2002;491-495
38. Nerad J.L., Griffiths J.K., Van der Meer J.W., Endres S., Poutsiaka D.D., Keusch G.T., Bennish M., Salam M.A., Dinarello C.A., Cannon J.G. Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J. Leukoc. Biol. 52:1992;687-692
39. Paciotti G., Barron D., Licinio J., Tamarkin L. Novel immunoassay for the detection of cytokines interleukin-1 alpha and interleukin-2 in the circulation of normal subjects. Prog. Neuroendocrinimmunology. 5:1992;21-30
40. Padberg F., Feneberg W., Schmidt S., Schwarz M.J., Korschenhausen D., Greenberg B.D., Nolde T., Muller N., Trapmann H., Konig N., Moller H.J., Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J. Neuroimmunol. 99:1999;218-223
41. Reder A.T., Lowy M.T., Meltzer H.Y., Antel J.P. Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy. Neurology. 37:1987;849-853
42. Reder A.T., Makowiec R.L., Lowy M.T. Adrenal size is increased in multiple sclerosis. Arch. Neurol. 51:1994;151-154
43. Rohleder N., Wolf J.M., Piel M., Kirschbaum C. Impact of oral contraceptive use on glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. Psychoneuroendocrinology. 28:2003;261-273
44. Samoilova E.B., Horton J.L., Hilliard B., Liu T.S., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:1998;6480-6486
45. Schonrock L.M., Gawlowski G., Bruck W. Interleukin-6 expression in human multiple sclerosis lesions. Neurosci. Lett. 294:2000;45-48
46. Sher E.R., Leung D.Y., Surs W., Kam J.C., Zieg G., Kamada A.K., Szefler S.J. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Invest. 93:1994;33-39
47. Smith C.C., Omeljaniuk R.J., Whitfield H.J. Jr., Aksentijevich S., Fellows M.Q., Zelazowska E., Gold P.W., Sternberg E.M. Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. Neuroimmunomodulation. 1:1994;66-73
48. Smits H.H., Grunberg K., Derijk R.H., Sterk P.J., Hiemstra P.S. Cytokine release and its modulation by dexamethasone in whole blood following exercise. Clin. Exp. Immunol. 111:1998;463-468
49. Sternberg E.M., Young W.S.R., Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., Wilder R.L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U. S. A. 86:1989;4771-4775
50. Straub R.H., Herfarth H., Falk W., Andus T., Scholmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease. J. Neuroimmunol. 126:2002;116-125
51. Tanaka H., Akama H., Ichikawa Y., Makino I., Homma M. Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy. J. Rheumatol. 19:1992;878-883
52. Then Bergh F., Grasser A., Trenkwalder C., Backmund H., Holsboer F., Rupprecht R. Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J. Neurol. 246:1999;292-298
53. Vacchio M.S., Ashwell J.D. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med. 185:1997;2033-2038
54. Vacchio M.S., Papadopoulos V., Ashwell J.D. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179:1994;1835-1846
55. van Oosten B.W., Truyen L., Barkhof F., Polman C.H. Multiple sclerosis therapy. A practical guide. Drugs. 49:1995;200-212
56. Wiegers G.J., Croiset G., Reul J.M., Holsboer F., de Kloet E.R. Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro. Am. J. Physiol. 265:1993;E825-E830
57. Wiegers G.J., Labeur M.S., Stec I.E., Klinkert W.E., Holsboer F., Reul J.M. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J. Immunol. 155:1995;1893-1902
58. Wilckens T. Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends Pharmacol. Sci. 16:1995;193-197
59. Wilckens T., De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today. 18:1997;418-424
60. Yang Y., Mercep M., Ware C.F., Ashwell J.D. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1995;1673-1682